NO20023823L - Fremgangsmåte for tilvirkning og bruk av pyrrolopyrimidinon- derivater - Google Patents
Fremgangsmåte for tilvirkning og bruk av pyrrolopyrimidinon- derivaterInfo
- Publication number
- NO20023823L NO20023823L NO20023823A NO20023823A NO20023823L NO 20023823 L NO20023823 L NO 20023823L NO 20023823 A NO20023823 A NO 20023823A NO 20023823 A NO20023823 A NO 20023823A NO 20023823 L NO20023823 L NO 20023823L
- Authority
- NO
- Norway
- Prior art keywords
- sub
- sup
- cycloalkyl
- optionally substituted
- fluoro atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20000007625A KR100358083B1 (ko) | 2000-02-17 | 2000-02-17 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
PCT/KR2001/000227 WO2001060825A1 (en) | 2000-02-17 | 2001-02-15 | Pyrrolopyrimidinone derivatives, process of preparation and use |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20023823D0 NO20023823D0 (no) | 2002-08-13 |
NO20023823L true NO20023823L (no) | 2002-10-09 |
NO323553B1 NO323553B1 (no) | 2007-06-11 |
Family
ID=19647449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20023823A NO323553B1 (no) | 2000-02-17 | 2002-08-13 | Fremgangsmate for tilvirkning og bruk av pyrrolopyrimidinon-derivater |
Country Status (23)
Country | Link |
---|---|
US (1) | US6962911B2 (no) |
EP (1) | EP1257553B1 (no) |
JP (1) | JP4845076B2 (no) |
KR (1) | KR100358083B1 (no) |
CN (1) | CN1312153C (no) |
AT (1) | ATE267829T1 (no) |
AU (2) | AU2001236140B9 (no) |
BR (1) | BRPI0108395B8 (no) |
CA (1) | CA2400268C (no) |
DE (1) | DE60103508T2 (no) |
DK (1) | DK1257553T3 (no) |
ES (1) | ES2222344T3 (no) |
HU (1) | HU230344B1 (no) |
IL (2) | IL151234A0 (no) |
MX (1) | MXPA02007942A (no) |
NO (1) | NO323553B1 (no) |
NZ (1) | NZ520842A (no) |
PL (1) | PL210796B1 (no) |
PT (1) | PT1257553E (no) |
RU (1) | RU2263676C2 (no) |
TR (1) | TR200402101T4 (no) |
WO (1) | WO2001060825A1 (no) |
ZA (1) | ZA200206587B (no) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100358083B1 (ko) * | 2000-02-17 | 2002-10-25 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
EP1362858A1 (en) * | 2002-05-15 | 2003-11-19 | SK Chemicals Co., Ltd. | Pyrrolopyrimidinone derivates, process of preparation and use |
DE10229778A1 (de) * | 2002-07-03 | 2004-01-29 | Bayer Ag | Neue Verwendung von Imidazotriazinonen |
FR2842809A1 (fr) * | 2002-07-26 | 2004-01-30 | Greenpharma Sas | NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |
CN100374441C (zh) | 2003-06-06 | 2008-03-12 | 天津倍方科技发展有限公司 | 二氢吡咯[2,3-d]嘧啶-4-酮衍生物,其制备方法及其制药用途 |
TW200745106A (en) * | 2005-10-03 | 2007-12-16 | Astrazeneca Ab | Chemical compounds |
KR20080003599A (ko) * | 2006-07-03 | 2008-01-08 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체의 겐티세이트 염 및 이의제조방법 |
MX2009000102A (es) * | 2006-07-03 | 2009-03-02 | Sk Chemicals Co Ltd | Sales de derivados de pirrolopirimidinona y proceso para prepararlas. |
KR101002490B1 (ko) * | 2007-06-09 | 2010-12-17 | 동아제약주식회사 | 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물 |
CA2777741A1 (en) | 2009-10-16 | 2011-04-21 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compounds and methods of making and using the same |
DK2488532T3 (en) | 2009-10-16 | 2018-08-13 | Melinta Therapeutics Inc | ANTIMICROBIAL COMPOUNDS AND PROCEDURES FOR PREPARING AND USING THE SAME |
DK2488525T3 (en) | 2009-10-16 | 2018-08-06 | Melinta Therapeutics Inc | ANTIMICROBIAL COMPOUNDS AND PROCEDURES FOR PREPARING AND USING THEREOF |
CN102970965A (zh) | 2010-04-05 | 2013-03-13 | Sk化学公司 | 含有pde5抑制剂的减少皮肤皱纹的合成物 |
CN102372730B (zh) * | 2010-08-19 | 2014-03-26 | 山东轩竹医药科技有限公司 | 桥环取代的磷酸二酯酶抑制剂 |
CN102134242B (zh) * | 2011-01-21 | 2013-08-28 | 浙江大德药业集团有限公司 | 一种用于治疗阳痿的快速长效的化合物 |
TWI490220B (zh) * | 2011-04-04 | 2015-07-01 | Sk Chemicals Co Ltd | 包含pde5抑制劑之用於減少皮膚皺紋之組成物 |
PT2697229T (pt) * | 2011-04-15 | 2018-04-13 | Melinta Therapeutics Inc | Compostos antimicrobianos e seus métodos de fabrico e de utilização |
CN103826638B (zh) | 2011-09-09 | 2015-11-25 | Sk化学公司 | 含有pde5 抑制剂的减少皮肤皱纹的组合物 |
CN109498628A (zh) | 2012-12-04 | 2019-03-22 | 株式会社阿丽浱欧 | 包含5型磷酸二酯酶抑制剂的神经细胞的细胞凋亡抑制用组合物的用途 |
KR20160070066A (ko) | 2013-09-09 | 2016-06-17 | 멜린타 테라퓨틱스, 인크. | 항균 화합물, 및 이의 제조 방법 및 이용 방법 |
CA2923179A1 (en) | 2013-09-09 | 2015-03-12 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
MX2017011616A (es) | 2015-03-11 | 2018-04-11 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos para hacerlos y usarlos. |
CN104744478B (zh) * | 2015-03-20 | 2016-08-24 | 中国人民解放军第二军医大学 | 一种防治辐射损伤的化合物、单晶及其制备方法和应用 |
AU2016355854B2 (en) | 2015-11-16 | 2021-05-06 | Topadur Pharma Ag | 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof |
JP2019515041A (ja) | 2016-05-06 | 2019-06-06 | メリンタ セラピューティクス、 インコーポレイテッドMelinta Therapeutics, Inc. | 抗菌剤ならびにそれを作製および使用する方法 |
CN118063458A (zh) * | 2017-05-22 | 2024-05-24 | 托帕杜制药公司 | 可溶性鸟苷酸环化酶激活剂和磷酸二酯酶抑制剂的新型双重作用模式及其用途 |
CN112566670A (zh) | 2018-08-06 | 2021-03-26 | 尼科斯股份有限公司 | 一氧化氮释放第5型磷酸二酯酶抑制剂 |
CN113166157A (zh) | 2018-11-28 | 2021-07-23 | 托帕杜制药公司 | 新型双作用模式可溶性鸟苷酸环化酶活化剂和磷酸二酯酶抑制剂及其用途 |
KR102271305B1 (ko) | 2020-05-21 | 2021-06-30 | 주식회사 아리바이오 | 치매 예방 및 치료용 조성물 |
WO2021245192A1 (en) | 2020-06-04 | 2021-12-09 | Topadur Pharma Ag | Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof |
CN111825593B (zh) * | 2020-08-19 | 2023-04-07 | 上海成澄科技有限公司 | 3-氨基吡咯-2-甲酰胺类化合物的合成方法 |
KR102272907B1 (ko) | 2020-11-05 | 2021-07-05 | 주식회사 아리바이오 | 치매 예방 및 치료용 조성물 |
KR102272910B1 (ko) | 2021-01-28 | 2021-07-06 | 주식회사 아리바이오 | 당뇨병을 동반한 치매 예방 및 치료용 조성물 |
KR20220140960A (ko) | 2021-04-12 | 2022-10-19 | 주식회사 아리바이오 | 당뇨병을 동반한 치매 예방 및 치료용 조성물 |
KR102311224B1 (ko) | 2021-04-23 | 2021-10-13 | 주식회사 아리바이오 | Pde5 억제제와 글루코코르티코이드 수용체 길항제 병용투여를 통한 치매 예방 및 치료용 조성물 |
KR20220146095A (ko) | 2021-04-23 | 2022-11-01 | 주식회사 아리바이오 | Pde5 억제제와 글루코코르티코이드 수용체 길항제 병용투여를 통한 치매 예방 및 치료용 조성물 |
KR20240064630A (ko) | 2021-09-29 | 2024-05-13 | 토파두르 파마 아게 | 2-페닐-3,4-디히드로피롤로[2,l-f][1,2,4]트리아지논 유도체의 국소 조성물 및 이들의 용도 |
WO2023166013A1 (en) | 2022-03-02 | 2023-09-07 | Topadur Pharma Ag | Topical compositions and uses therof |
KR20230129639A (ko) * | 2022-03-02 | 2023-09-11 | 연세대학교 산학협력단 | 이중작용 pde5 억제제/질산유기에스터의 국소 혈류 증진을 위한 경피 투약 형태 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5761734B2 (no) * | 1973-09-27 | 1982-12-25 | Takeda Chemical Industries Ltd | |
JPS5761734A (en) * | 1980-10-02 | 1982-04-14 | Teijin Ltd | Spun like fabric |
GB9013750D0 (en) * | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9311920D0 (en) * | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
JP3713783B2 (ja) * | 1995-01-20 | 2005-11-09 | 大正製薬株式会社 | 1H−ピラゾロ[3,4−d]ピリミジン−4−オン誘導体 |
CZ299633B6 (cs) * | 1997-04-25 | 2008-09-24 | Pfizer Inc. | Pyrazolopyrimidinony, meziprodukty pro jejich výrobu a farmaceutické a veterinární kompozice na jejich bázi |
HUP0102543A3 (en) * | 1998-04-20 | 2002-01-28 | Pfizer | Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction and medicaments containing them |
KR100358083B1 (ko) * | 2000-02-17 | 2002-10-25 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
-
2000
- 2000-02-17 KR KR20000007625A patent/KR100358083B1/ko active IP Right Grant
-
2001
- 2001-02-15 IL IL15123401A patent/IL151234A0/xx unknown
- 2001-02-15 HU HU0300527A patent/HU230344B1/hu unknown
- 2001-02-15 RU RU2002124872/04A patent/RU2263676C2/ru active
- 2001-02-15 US US10/204,327 patent/US6962911B2/en not_active Expired - Lifetime
- 2001-02-15 NZ NZ520842A patent/NZ520842A/en not_active IP Right Cessation
- 2001-02-15 AT AT01908397T patent/ATE267829T1/de active
- 2001-02-15 CA CA002400268A patent/CA2400268C/en not_active Expired - Lifetime
- 2001-02-15 EP EP01908397A patent/EP1257553B1/en not_active Expired - Lifetime
- 2001-02-15 AU AU2001236140A patent/AU2001236140B9/en not_active Expired
- 2001-02-15 MX MXPA02007942A patent/MXPA02007942A/es active IP Right Grant
- 2001-02-15 BR BRPI0108395A patent/BRPI0108395B8/pt not_active IP Right Cessation
- 2001-02-15 PT PT01908397T patent/PT1257553E/pt unknown
- 2001-02-15 JP JP2001560209A patent/JP4845076B2/ja not_active Expired - Lifetime
- 2001-02-15 PL PL358188A patent/PL210796B1/pl unknown
- 2001-02-15 ES ES01908397T patent/ES2222344T3/es not_active Expired - Lifetime
- 2001-02-15 WO PCT/KR2001/000227 patent/WO2001060825A1/en active IP Right Grant
- 2001-02-15 DK DK01908397T patent/DK1257553T3/da active
- 2001-02-15 DE DE60103508T patent/DE60103508T2/de not_active Expired - Lifetime
- 2001-02-15 CN CNB018075002A patent/CN1312153C/zh not_active Expired - Lifetime
- 2001-02-15 AU AU3614001A patent/AU3614001A/xx active Pending
- 2001-02-15 TR TR2004/02101T patent/TR200402101T4/xx unknown
-
2002
- 2002-08-13 NO NO20023823A patent/NO323553B1/no not_active IP Right Cessation
- 2002-08-13 IL IL151234A patent/IL151234A/en active IP Right Grant
- 2002-08-16 ZA ZA200206587A patent/ZA200206587B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20023823L (no) | Fremgangsmåte for tilvirkning og bruk av pyrrolopyrimidinon- derivater | |
BE2018C008I2 (no) | ||
CY1108269T1 (el) | Παραγωγα της αβερμεκτινης β1 που εχουν εναν αμινοσουλφονυλοξυ υποκαταστατη στη θεση 4" | |
WO2001077107A8 (en) | Oxazole derivatives and their uses as tyrosine kinase inhibitors | |
NO20031001L (no) | Polyarylkarboksamider nyttige som lipidsenkende midler | |
SE0000540D0 (sv) | New compounds | |
DK1414302T3 (da) | 7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe | |
DK0862562T3 (da) | Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler | |
DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
ES8607226A1 (es) | Un procedimiento para la preparacion de un compuesto | |
AU3415599A (en) | Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents | |
NO20062936L (no) | Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav | |
HUP0400165A2 (hu) | Benzoilpirazolokat és antidótumokat tartalmazó herbicid szerek | |
NZ332923A (en) | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | |
ATE550332T1 (de) | 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors | |
DK0544587T3 (da) | Hidtil ukendte alpha-methylen-2-vinylbenzeneddikesyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse som pesticider | |
NO20022279L (no) | Beta-D-5-tioxylose-derivater, fremstillingsmåte og terapeutisk anvendelse | |
DE59106102D1 (de) | Herbizide Sulfonylharnstoffe, Verfahren und Zwischenprodukte zu ihrer Herstellung. | |
HUP0301561A2 (hu) | Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására | |
ATE284379T1 (de) | Aminderivate | |
HUP0300381A2 (hu) | Új kapcsolási eljárás | |
HUP0301741A2 (hu) | Eljárás 4-bróm-anilin-származékok előállítására | |
ES483557A1 (es) | Procedimiento para la preparacion de derivados de imidazol | |
HUP0302576A2 (hu) | Fungicid keverékek | |
TH58475B (th) | อนุพันธุ์ของ 1,4-ไดอะซาไบไซโคล [3.2.2]โนเนน-4-คาร์บอกซีเลต และ คาร์บอกซามีด การเตรียมและการใช้รักษาโรค |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |